Medi Labz

12-lead notes · ECG Simulator

Left ventricular hypertrophy

Clinical review pending: written from the sources below, not yet checked by a clinician. Updated 2026-11-22.

Wave size
Leads V1, V5, V6 · small box: 40 ms across, 0.1 mV up

In one line

A thickened left ventricle makes more electricity and takes longer to depolarize: very tall QRS voltages in the left chest leads, deep S waves on the right, often a leftward axis and lateral "strain" ST–T changes.1,2

Mechanism

  • More muscle, more voltage. A larger muscle mass generates larger electrical potentials, so the QRS voltages grow.1
  • Longer path, longer QRS. Depolarization takes longer through a thick or dilated ventricle, so the QRS may widen slightly, to about 0.09–0.12 s (normal is 0.06–0.08 s).1
  • Axis shift. The normal right ventricle finishes first, leaving a strong vector toward the hypertrophied left side: the axis moves left.1
  • Strain pattern. Repolarization in the thick wall is altered, so ST depression and T inversion appear in the leads with tall R waves (I, aVL, V5–V6).1,2
  • The usual trigger is a pressure or volume load on the left ventricle.1

Epidemiology

  • In the Framingham Heart Study, an ECG pattern of LVH was recognized as a warning sign of later cardiovascular disease and death.3
  • Among 3,220 Framingham adults without heart disease, each 50 g/m rise in left ventricular mass on echocardiography raised the adjusted risk of cardiovascular disease by about 1.5 times, and of cardiovascular death by about 1.7–2.1 times.3
  • The ECG misses many people who have LVH on imaging: voltage criteria are fairly specific but not sensitive.2

Causes and risk factors

  • Hypertension: the most common cause.1,2
  • Aortic stenosis and aortic regurgitation.1
  • Hypertrophic cardiomyopathy.2
  • Congenital heart disease that loads the left ventricle.1
  • Athletic training can raise voltages without disease; voltage alone is not enough to diagnose LVH in athletes.4

How to spot it

  1. Voltage, chest leads: the S in V1 plus the R in V5 or V6 over 3.5 mV (35 small boxes at standard gain), the Sokolow–Lyon criterion.2
  2. Voltage, limb leads: for example the R in aVL plus the S in V3 over 2.8 mV in men or 2.0 mV in women (Cornell criteria).2
  3. Strain: downsloping ST depression and asymmetric T inversion in I, aVL, V5–V6.1,2
  4. Axis: often shifted left.1
  5. QRS: may be slightly prolonged.1
  6. Left atrial enlargement: a broad, notched P wave often comes with it.2

Differential diagnosis

  • Normal high voltage in young, thin or athletic people, without strain changes.2,4
  • Left bundle branch block: wider QRS (120 ms or more) and no septal q waves; voltage criteria are not reliable in LBBB.2,5
  • Ischemia: ST depression and T inversion without high voltage.1,6
  • Right ventricular hypertrophy: tall R in V1 and right axis, the mirror image.2

Clinical picture

  • LVH itself is silent. Any symptoms come from its cause, such as hypertension or valve disease, or from the cardiovascular disease it predicts.1,3

Why it matters

  • LVH is a marker of long-standing load on the heart and predicts cardiovascular events and death.3
  • Echocardiography adds prognostic information beyond risk factors and the ECG.3

Management overview

For learning only. This is the shape of care, not a treatment plan; real decisions depend on the patient and the current guideline.

  • Confirm with echocardiography (or cardiac MRI), because the ECG is insensitive.2,3
  • Treat the cause: control blood pressure, assess and treat valve disease.1,3
  • Reduce overall cardiovascular risk.3

Exam pearls

  • SV1 + RV5/V6 over 35 mm: Sokolow–Lyon LVH.2
  • High voltage alone in a young athlete is usually normal; voltage plus strain, left atrial enlargement or left axis is more convincing.2,4
  • Lateral ST depression with tall R waves = strain, not necessarily ischemia.1,2
  • Do not apply LVH voltage criteria to an LBBB tracing.2,5

Sources

Where this comes from.

  1. Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology, 14th ed. Elsevier; 2021. Ch. 12 (pp. 149, 151, 156).
  2. Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram, Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy. Circulation. 2009;119(10):e251–e261. doi.org/10.1161/CIRCULATIONAHA.108.191097
  3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561–6. doi.org/10.1056/NEJM199005313222203
  4. Drezner JA, Sharma S, Baggish A, et al. International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med. 2017;51(9):704–731. doi.org/10.1136/bjsports-2016-097331
  5. Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram, Part III: Intraventricular Conduction Disturbances. Circulation. 2009;119(10):e235–e240. doi.org/10.1161/CIRCULATIONAHA.108.191095
  6. Wagner GS, Macfarlane P, Wellens H, et al. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram, Part VI: Acute Ischemia/Infarction. Circulation. 2009;119(10):e262–e270. doi.org/10.1161/CIRCULATIONAHA.108.191098